Altimmune’s Promising GLP-1 Drug: Worth the Investment?
Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
- Latest
- Trending
Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Two Chinese nationals have been convicted for submitting fake iPhones to Apple for repair, attempting to defraud the company of ...
Post Time and Apple Picker secured back-to-back graded stakes wins for trainer Brittany Russell and jockey Sheldon Russell at Laurel ...
Apple Pay is experiencing an outage that is affecting Chase customers. Many users have reported their Chase cards being declined ...
American electric vehicle manufacturer Fisker Inc. expands its US dealer network to strengthen distribution of electric vehicles, including the Fisker ...
Mon Power and Potomac Edison have proposed a settlement on net energy metering rates in West Virginia, aiming to balance ...
Maryland proposes legislation to regulate concert ticket resales, aiming to protect consumers from exorbitant prices and deceptive practices. The bill ...
W.R. Grace & Co partners with China Coal Shaanxi to double polypropylene production, meeting growing global demand for high-quality products.
A federal grand jury charged "Bitcoin Rodney" and two others with orchestrating a $1.89 billion cryptocurrency fraud scheme. They falsely ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.